CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 77-85

  Galibert, Laurent ^a   Burdin, Nicolas ^a   De Saint Vis, Blandine ^a   Garrone, Pierre ^a   Van Kooten, Cees ^a   Banchereau, Jacques ^a   Rousset, Françoise ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CARBOXYPEPTIDASE; CD19 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; FAS ANTIGEN; GAMMA INTERFERON; LYMPHOCYTE RECEPTOR; RECEPTOR ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; GERMINAL CENTER; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, CD40; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; GERMINAL CENTER; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; N-GLYCOSYL HYDROLASES; PHENOTYPE; RECEPTORS, ANTIGEN, B-CELL; TONSIL;

EID: 0030061131     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.77     Document Type: Article

References (50)

1. Nossal, G.J. 1994. Differentiation of the secondary B-lymphocyte repertoire: the germinal center reaction. Immunol. Rev. 137:173-183.
2. MacLennan, I.C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-139.
3. Gelman, L., P. Deterre, H. Gouy, L. Boumsell, P. Debre, and G. Bismuth. 1993. The lymphocyte surface antigen CD38 acts as a nicotinamide adenine dinucleotide glycohydrolase in human T lymphocytes. Eur. J. Immunol. 23:3361-3364.
4. Howard, M., J.C. Grimaldi, J.F. Bazan, F.E. Lund, A.L. Santos, R.M. Parkhouse, T.F. Walseth, and H.C. Lee. 1993. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science (Wash. DC). 262:1056-1059.
5. Nishina, H., K. Inageda, K. Takahashi, S. Hoshino, K. Ikeda, and T. Katada. 1994. Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity. Biochem. Biophys. Res. Commun. 203:1318-1323.
6. Summerhill, R.J., D.G. Jackson, and A. Galione. 1993. Human lymphocyte antigen CD38 catalyzes the production of cyclic ADP-ribose. FEBS Lett. 335:231-233.
7. Takasawa, S., A. Tohgo, N. Noguchi, T. Koguma, K. Nata, T. Sugimoto, H. Yonekura, and H. Okamoto. 1993. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J. Biol. Chem. 268:26052-26054.
8. Zupo, S., E. Rugari, M. Dono, G. Taborelli, F. Malavasi, and M. Ferrarini. 1994. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells. Eur. J. Immunol. 24:1218-1222.
9. De Saint-Vis, B., L. Cupillard, D. Pandrau-Garcia, S. Ho, N. Renard, G. Grouard, V. Duvert, X. Thomas, J. Galizzi, J. Banchereau, and S. Saeland. 1995. Distribution of carboxypeptidase-M on lymphoid and myeloid cells parallels the other zinc-dependent proteases CD10 and CD13. Blood. 86: 1098-1105.
10. Garrone, P., E.-M. Neidhardt, E. Garcia, L. Galibert, C. Van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265-1273.
11. Lagresle, C., C. Bella, P.T. Daniel, P.H. Krammer, and T. Defrance. 1995. Regulation of germinal center B cell differentiation. Role of the human Apo-1/Fas (CD95) molecule. J. Immunol. 154:5746-5756.
12. Vallé, A., C.E. Zuber, T. Defrance, O. Djossou, M. De Rie, and J. Banchereau. 1989. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19: 1463-1467
13. Dive, C., C.D. Gregory, D.J. Phipps, D.L. Evans, A.E. Milner, and A.H. Wyllie. 1992. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta. 1133:275-285.
14. - B cell compartment: identification of two major tonsillar B cell subsets. Int. Immunol 5:1259-1268.
15. Pascual, V., Y.-J. Liu, A. Magalski, O. de Bouteiller, J. Banchereau, and J.D. Capra. 1994. Analysis of somatic mutation in five B cell subsets of human tonsil. J. Exp Med. 180: 329-339.
16. Liu, Y.-J., C. Barthelemy, O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau. 1995. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid upregulation of B7.1 and B7.2. Immunity. 2:239-248.
17. Wheeler, K., J.D. Pound, J. Gordon, and R. Jefferis. 1993. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur. J. Immunol. 23:1165-1168.
18. Sumimoto, S., T. Ishigami, Y. Horiguchi, S. Yonehara, S. Kanazashi, T. Heike, K. Katamura, and M. Mayumi. 1994. Anti-Fas antibody induces different types of cell death in the human histiocytic cell line, U937, and the human B cell line, B104: the role of single-strand DNA breaks and poly (ADP-ribosyl)ation in cell death. Cell. Immunol. 153:184-193.
19. Connelly, J., R. Chambless, D. Holiday, K. Chittenden, and A. Johnson. 1993. Upregulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor. J. Leukocyte Biol. 53:685-690.
20. Wayner, E.A., and W.G. Carter. 1987. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J. Cell. Biol. 105:1873-1884.
21. Liu, Y.J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C. MacLennan. 1989 Mechanism of antigen-driven selection in germinal centres. Nature (Lond.). 342:929-931.
22. Kroese, F.G., W. Timens, and P. Nieuwenhuis. 1990. Germinal center reaction and B lymphocytes, morphology and function. Curr. Top. Pathol. 84:103-148.
23. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
24. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
25. Renshaw, B.R., W.C. Fanslow, III, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
26. Notarangelo, L.D., M. Duse, and A.G. Ugazio. 1992. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3: 101-121.
27. Allen, R.C., R.J. Armitage, M.E. Conley, H. Rosenblatt, N.A. Jenkins, N.G. Copeland, M.A. Bedell, S. Edelhoff, C.M. Disteche, D.K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science (Wash. DC). 259:990-993.
28. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
29. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. de Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:541-543
30. Korthauer, U., D. Graf, H.W. Mages, F. Briere, M. Padayachee, S Malcolm, A.G. Ugazio, L.D. Notarangelo, R.J. Levinsky, and R.A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361:539-541.
31. Ranheim, E.A., and T.J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925-935.
32. Azuma, M., D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier, and C. Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.). 366:76-79.
33. Ling, N., I. MacLennan, and D. Mason. 1987. B cell and plasma cell antigens: new and previously defined clusters. In Leukocyte Typing III. A.J. McMichael, editor. 302-335.
34. Khan, N.U., K.A. Pulford, M A. Farquharson, A. Howatson, C. Stewart, R. Jackson, A.M. McNicol, and A.K. Foulis. 1909. The distribution of immunoreactive interferon-alpha in normal human tissues. Immunology. 66:201-226.
35. Quiding, M., G. Granstrom, I. Nordstrom, B. Ferrua, J. Holmgren, and C. Czerkinsky. 1993. High frequency of spontaneous interferon-gamma-producing cells in human tonsils: role of local accessory cells and soluble factors. Clin. Exp. Immunol. 91:157-163.
36. Hoefakker, S., E.H. van't Erve, C. Deen, A.J. Van den Eertwegh, W.J. Boersma, W.R. Notten, and E. Claassen. 1993. Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils. Clin. Exp. Immunol. 93:223-228.
37. Lederman, S , M.J. Yellin, G. Inghirami, J.J. Lee, D.M. Knowles, and L. Chess. 1992. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J. Immunol. 149:3817-3826.
38. Van den Eertwegh, A.J., R.J. Noelle, M. Roy, D.M. Shepherd, A. Aruffo, J.A. Ledbetter, W.J. Boersma, and E. Claassen. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp Med. 178: 1555-1565.
39. - memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp. Med. 181:1293-1301.
40. Cooke, M.P., A.W. Heath, K.M. Shokat, Y. Zeng, F.D. Finkelman, P.S. Linsley, M. Howard, and C.C. Goodnow. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425-438.
41. + T cells. J. Exp. Med. 179:1539-1549.
42. low T cells. Eur. J. Immunol. 24:2993-2999.
43. Kosco-Vilbois, M.H., D. Gray, D. Scheidegger, and M. Julius. 1993. Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules. J. Exp. Med. 178:2055-2066.
44. Rickert, R.C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (Lond.). 376:352-355.
45. Maloney, M.D., and C.A. Lingwood. 1994. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 180:191-201.
46. Fearon, D.T. 1993. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. Curr. Opin. Immunol. 5:341-348.
47. Tedder, T.F., L.J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today. 15:437-442.
48. Weigent, D.A., M.P. Langdord, E.M. Smith, J.E. Ballock, and G.J. Stanton. 1981. Human B lymphocytes produce leucocyte interferon after interaction with foreign cells. Infect. Immun. 32:508-515.
49. van Kooten, C., C. Gaillard, J.P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24:787-792.
50. Yellin, M.J., K. Sippel, G. Inghirami, L.R. Covey, J.J. Lee, J. Sinning, E.A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J. Immunol. 152:598-608.